Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Adagrasib oral dose of 400 mg twice daily's trials
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation
Adagrasib oral dose of 400 mg twice daily tablets
Ongoing
Active not recruiting
Phase 2
Open NCT05609578 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
